Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Quest Diagnostics (DGX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,756 | 0.01 | Reduce 88.47% | 0.04 | $195.98 | $540,121 | SEC |
| 2025 Q4 | 23,895 | 0.04 | Add 31.45% | <0.01 | $173.53 | $4,146,499 | SEC |
| 2025 Q3 | 18,178 | 0.05 | Buy | 0.05 | $190.58 | $3,464,363 | SEC |
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2023 Q2 | 8,046 | 0.02 | Add 45.16% | <0.01 | $140.56 | $1,130,946 | SEC |
| 2023 Q1 | 5,543 | 0.02 | Buy | 0.02 | $141.48 | $784,224 | SEC |
| 2021 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2021 Q1 | 2,441 | <0.01 | Add 288.69% | <0.01 | $128.23 | $313,000 | SEC |
| 2020 Q4 | 628 | <0.01 | Buy | <0.01 | $119.43 | $75,000 | SEC |
| 2016 Q4 | 0 | 0.00 | Sell 100.00% | 0.04 | SEC | ||
| 2016 Q3 | 37,510 | 0.04 | Buy | 0.04 | $84.62 | $3,174,000 | SEC |
| 2000 Q3 | 0 | 0.00 | Sell 100.00% | 1.04 | SEC | ||
| 2000 Q2 | 700,400 | 1.04 | Add 20.80% | 0.18 | $74.75 | $52,355,000 | SEC |
| 2000 Q1 | 579,800 | 0.51 | Buy | 0.51 | $39.75 | $23,047,000 | SEC |